Cochlear | COH - Cash And Equivalent

Stock Price
250.17
Daily Change
-8.57 -3.31%
Monthly
-4.74%
Yearly
-19.25%
Q1 Forecast
263.64

Cochlear reported AUD275.7M in Cash and Equivalent for its fiscal semester ending in June of 2025.





Cash And Equivalent Change Date
Ansell USD 238.3M 674M Jun/2025
Avita Medical AUD 12.22M 1.83M Jun/2025
Cochlear AUD 275.7M 107.4M Jun/2025
CSL USD 2.16B 633M Jun/2025
Fisher Paykel Healthcare NZD 89.9M 13.3M Jun/2022
Healius AUD 60.1M 25.6M Jun/2024
Integral Diagnostics AUD 17.99M 15.86M Dec/2023
Mayne Pharma AUD 110.07M 838K Jun/2024
Mesoblast USD 62.56M 14.58M Jun/2024
Monash IVF AUD 9.43M 1.93M Jun/2025
Nanosonics AUD 161.29M 156.45M Jun/2025
Polynovo AUD 45.91M 330K Jun/2024
Ramsay Health Care AUD 784.4M 443.3M Jun/2025
Regis Healthcare AUD 192.46M 127.56M Jun/2025
ResMed USD 1.42B 33.22M Dec/2025
Sigma Healthcare AUD 16.65M 3.68M Jan/2023
Sonic Healthcare AUD 645M 25.39M Jun/2024
Telix Pharmaceuticals AUD 710.35M 587.11M Dec/2024